Microplastics impair wound healing via NAT10-mediated epigenetic dysregulation of FASN-PI3K/AKT signaling
NanoImpact · 2025
DOI: 10.1016/j.impact.2025.100580 ↗Kurz gefasst
Fachartikel in der Zeitschrift NanoImpact, 2025. Verfasst von Feng-Jie Shen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Key Laboratory of Diabetes Research and Care, Department of Endocrinology, Beijing Diabetes Institute, Beijing Tongren Hospital, Capital Medi…. Hauptthemen laut MEDLINE: Microplastics, Wound Healing, Environmental Pollutants, Polystyrenes. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Key Technologies Research and Development Program.
Themen: Wundversorgung
Abstract (Originalsprache)
Microplastics (MPs) are environmental pollutants with potential health risks. This study examined the effect of MPs on wound healing in both diabetic and non-diabetic mice. MPs exposure significantly delayed wound healing, particularly in diabetic mice, with reduced epidermal thickness and impaired collagen deposition. Mechanistically, MPs suppressed cell proliferation, angiogenesis, and increased apoptosis. Transcriptomic analysis identified dysregulation of critical wound healing pathways, especially those involved in inflammation, extracellular matrix remodeling, and lipid metabolism. Notably, the PI3K/AKT signaling pathway was inhibited. In vitro experiments using human dermal fibroblasts confirmed that MPs disrupted the PI3K/AKT pathway, reducing cell proliferation and migration. Further investigation revealed that MPs suppressed N-acetyltransferase 10 (NAT10) expression, leading to reduced ac4C-dependent stabilization of Fasn mRNA, which in turn diminished lipid synthesis and further inhibited the PI3K/AKT pathway. Our findings reveal a novel interaction between MPs and diabetes in impairing wound healing and suggest the NAT10-FASN-PI3K/AKT axis as a potential therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beijing Key Laboratory of Diabetes Research and Care, Department of Endocrinology, Beijing Diabetes Institute, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China.
- Xinjiang Medical University, Department of Cardiology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi 830000, China.
- Department of Nephrology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China.
- Beijing Key Laboratory of Diabetes Research and Care, Department of Endocrinology, Beijing Diabetes Institute, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China. Electronic address: gangwei_201…
- Beijing Key Laboratory of Diabetes Research and Care, Department of Endocrinology, Beijing Diabetes Institute, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China. Electronic address: jkyang@ccmu…
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Key Technologies Research and Development Program
Zitieren
APA
Shen, F. J., Cao, W. N., Han, X. C., Pan, Q. Y., Wang, Y., Zhang, R., Wei, G., & Yang, J. K. (2025). Microplastics impair wound healing via NAT10-mediated epigenetic dysregulation of FASN-PI3K/AKT signaling. NanoImpact. https://doi.org/10.1016/j.impact.2025.100580
Vancouver
Shen FJ, Cao WN, Han XC, Pan QY, Wang Y, Zhang R, et al. Microplastics impair wound healing via NAT10-mediated epigenetic dysregulation of FASN-PI3K/AKT signaling. NanoImpact. 2025. doi:10.1016/j.impact.2025.100580
BibTeX
@article{Shen2025,
author = {Shen, Feng-Jie and Cao, Wei-Nan and Han, Xue-Chun and Pan, Qiu-Yue and Wang, Yuan and Zhang, Rong and Wei, Gang and Yang, Jin-Kui},
title = {Microplastics impair wound healing via NAT10-mediated epigenetic dysregulation of FASN-PI3K/AKT signaling},
journal = {NanoImpact},
year = {2025},
doi = {10.1016/j.impact.2025.100580}
}
EUVIMED